Krystal Biotech, Inc. (KRYS)
296.35
+7.36
(+2.55%)
USD |
NASDAQ |
May 07, 16:00
298.50
+2.15
(+0.73%)
After-Hours: 20:00
Krystal Biotech Research and Development Expense (Annual) : 52.32M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Scholar Rock Holding Corp. | 206.78M |
| Stoke Therapeutics, Inc. | 136.15M |
| Moderna, Inc. | 2.917B |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| TG Therapeutics, Inc. | 160.22M |